Unification Of Chinese Health Info Faces Difficulties From Lack Of Funding
This article was originally published in PharmAsia News
An industry study found imbalance in the unification of China's healthcare information, with that of more prosperous regions with higher class hospitals more developed than others
You may also be interested in...
The US FDA’s decision to ask on device adverse event reports whether the device involved had been serviced by a third party could help the agency as well as device makers, says Ricki Chase, compliance practice director at Lachman Consultant Services.
The FDA has almost 30 decision dates coming up before New Year’s Eve, including nearly a dozen novel agents.
Complaint lists host of problems with implementation of the rule that allows states to sponsor programs to import certain prescription drugs from Canada; at least six states have enacted legislation to sponsor these programs.